.jpg)
21 hours ago
4
Article content
Connected datasets provide a 360° view of the patient
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) — Citeline, a Norstella company and leading provider of clinical, drug and commercial intelligence for the life sciences industry, introduces Patient Intelligence, providing a complete view of the patient to help teams make patient-first decisions across clinical trial feasibility and protocol planning.
Article content
Article content
Patient Intelligence unites robust patient data with the trusted trial, site and pipeline intelligence of Cite line’s Trialtrove, Sitetrove and Pharmaprojects. These datasets feed workflows across the Citeline platform, including trial design, site selection and patient recruitment planning.
Article content
Article content
Patient Intelligence is comprised of:
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
- Patient Population: Global epidemiology data combines with country-level mapping to reveal whether there is a sizable patient population for a given disease and where it is located.
- Standard of Care: A live view of the treatment landscape for a given disease, starting with oncology using guideline-recommended regimens by biomarker, therapy line and region, helps clients deepen their understanding of the patient standard of care recommendations.
- Patient Journey: Drawing on the depth of de-identified real-world data (RWD) within NorstellaLinQ, this approach brings together open claims, electronic health records (EHR) and clinical notes and social determinants of health (SDOH) to create a more complete view of the patient. By connecting clinical signals across the patient journey, from diagnosis and treatment decisions to line-of-therapy progression and transitions in care, it captures the clinical nuance and context often missed by individual data sources alone, enabling more precise protocol-to-patient targeting.
- Patient Access and Proximity: Built into Sitetrove and mapped to investigator and site records, this capability uses open claims and SDOH data from NorstellaLinQ to pinpoint sites and investigators with access to relevant and diverse patient populations across the US and 19 additional countries, and identifies US physicians near those investigators who have access to the right patients for referral.
Article content
Article content
Together, these datasets also help connect patients to providers and sites, for optimized patient recruitment. In addition, based on the selected indication, Patient Intelligence pulls in relevant advocacy groups and enables sponsors to network with them for possible recruitment.
Article content
“Every successful clinical trial starts with a patient,” says Madeline Naylor, Citeline Chief Clinical Officer. “Patient Intelligence brings the patient layer into Citeline’s AI-ready foundation of pipeline, trial and site data, all in one trusted source of truth.
Article content
“We’re not just helping sponsors understand pipelines, trials, sites and investigators in isolation, we’re helping them to connect those decisions back to the patient,” she says. “Patient Intelligence helps teams bring patient reality into the decisions that shape a trial from the very beginning.”
Article content
To learn more about Patient Intelligence, visit Citeline.com.
Article content
About Citeline
Article content
Citeline, backed by the strength of Norstella, the AI company for biopharma’s highest-stakes decisions, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical-, commercial- and regulatory-related decisions and create real-world opportunities for growth.
Article content
Citeline’s global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering them all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. For more information on one of the world’s most trusted health science partners, visit Citeline and follow on LinkedIn and X.
Article content
Media Contact
Article content
Article content
Article content
Article content
Article content
Article content
Article content
English (US)